Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Allogeneic bone marrow derived mesenchymal stromal cells, ex-vivo expanded

EU orphan designation number: EU/3/18/2044   
Active ingredient: Allogeneic bone marrow derived mesenchymal stromal cells, ex-vivo expanded
Indication: Treatment of graft-versus-host disease
Sponsor: medac Gesellschaft für klinische Spezialpräparate mbH
Theaterstraße 6, 22880 Wedel, Deutschland

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
2/08/2018 Orphan designation EMA/OD/023/18 (2018)5276 of 31/07/2018